[Long-term remission of a patient with Sézary syndrome treated with chidamide combined with PD-1 blockade: a case report]

Zhonghua Xue Ye Xue Za Zhi. 2022 Feb 14;43(2):165. doi: 10.3760/cma.j.issn.0253-2727.2022.02.016.

[Article in Chinese]

Authors

C Wei¹, Y Zhang¹, W Zhang¹, D B Zhou¹

Affiliation

¹ Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.

PMID: 35381682
PMCID: PMC8980642
DOI: 10.3760/cma.j.issn.0253-2727.2022.02.016

No abstract available

Publication types

Case Reports

MeSH terms

Aminopyridines
Benzamides
Humans
Programmed Cell Death 1 Receptor
Sezary Syndrome* / drug therapy
Skin Neoplasms* / drug therapy

Substances

Aminopyridines
Benzamides
Programmed Cell Death 1 Receptor
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide